Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Improvements in Health-Related Quality of Life after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease

Akshay Sharma, Haydar Frangoul, Markus Mapara, Suzan Imren, Nanxin Li, Tina Liu, Jaime Rubin, Daoyuan Shi, William Hobbs, Stephan Grupp

Blood (2023) 142 (Supplement 1): 4999.

https://doi.org/10.1182/blood-2023-190203

Published: 2023

Journal Articles

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Blood (2023) 142 (Supplement 1): 1052.

https://doi.org/10.1182/blood-2023-190139

Published: 2023

Journal Articles

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Blood (2023) 142 (Supplement 1): 1053.

https://doi.org/10.1182/blood-2023-190534

Published: 2023

Journal Articles

Improvements in Health-Related Quality of Life after Exagamglogene Autotemcel in Patients with Transfusion-Dependent Beta-Thalassemia

Franco Locatelli, Peter Lang, Selim Corbacioglu, Donna Wall, Amanda M Li, Josu de La Fuente, Puja Kohli, Nanxin Li, Jaime Rubin, Siyu Zhang, Lanju Zhang, William Hobbs, Haydar Frangoul

Blood (2023) 142 (Supplement 1): 4997.

https://doi.org/10.1182/blood-2023-179916

Published: 2023

Journal Articles

AsCas12a Gene Editing of HBG1/2 Promoters with EDIT-301 Results in Rapid and Sustained Normalization of Hemoglobin and Increased Fetal Hemoglobin in Patients with Severe Sickle Cell Disease and Transfusion-Dependent Beta-Thalassemia

Rabi Hanna, Haydar Frangoul, Christopher McKinney, Luis Pineiro, Markus Mapara, Jignesh Dalal, Kai-Hsin Chang, Michael Jaskolka, Keunpyo Kim, Daphne L. Farrington, Maha Wally, Baisong Mei, Adebayo Lawal, Olubunmi O. Afonja, Mark C. Walters

Blood (2023) 142 (Supplement 1): 4996.

https://doi.org/10.1182/blood-2023-187397

Published: 2023

Journal Articles

Differing Definitions of Vaso-Occlusion in Clinical Studies of Sickle Cell Disease Can Result in Differing Outcomes

Haydar Frangoul, Suzan Imren, Fengjuan Xuan, Nanxin Li, Jaime Rubin, William Hobbs, Franco Locatelli

Blood (2023) 142 (Supplement 1): 7107.

https://doi.org/10.1182/blood-2023-189246

Published: 2023

Journal Articles

Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Blood (2022) 140 (Supplement 1): 4899–4901.

https://doi.org/10.1182/blood-2022-166881

Published: 2022

Journal Articles

Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Severe Sickle Cell Disease

Haydar Frangoul, Franco Locatelli, Monica Bhatia, Markus Y. Mapara, Lyndsay Molinari, Akshay Sharma, Stephan Lobitz, Mariane de Montalembert, Damiano Rondelli, Martin Steinberg, Mark C. Walters, Suzan Imren, Lanju Zhang, Anjali Sharma, Yang Song, Christopher Simard, William Hobbs, Stephen Grupp

Blood (2022) 140 (Supplement 1): 29–31.

https://doi.org/10.1182/blood-2022-162353

Published: 2022

Journal Articles

Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+ Hematopoietic Stem and Progenitor Cells

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-139575

Published: 2020

Journal Articles

Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN)

Minoo Battiwalla, MD, Carlos Bachier, MD, Vikas Bhushan, MD, Michael J. Eckrich, MD MPH, Alireza Eghtedar, MD, Haydar Frangoul, MD, Suman Kambhampati, MD, Shahbaz Malik, MD, Peter A. McSweeney, MD, Jeremy Pantin, MBBS, Aravind Ramakrishnan, MD, Hana Safah, MD, Paul J Shaughnessy, MD, Betsy Blunk, BSN, RN, BMTCN, Tonya Cox, BSN, RN, Rocky Billups, MS, Charles F. Lemaistre, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-139121

Published: 2020

Journal Articles

Comparison of Outcomes for Myeloablative Conditioning Regimens Combining Busulfan with Either Cyclophosphamide or Fludarabine in Children

Andrew C. Harris, MD, Jaap Jan Boelens, MDPhD, Kwang Woo Ahn, PhD, Mingwei Fei, MS, Allistair Abraham, MD, Andrew Artz, MD, Christopher C. Dvorak, MD, Haydar Frangoul, MD, Cesar O Freytes, MD, Robert Peter Gale, MD PhD, Sanghee Hong, MD, Hillard M. Lazarus, MD, Shin Mineishi, MD, Taiga Nishihori, MD, Tracey O'Brien, MD, Kirsten M. Williams, MD, Marcelo C. Pasquini, MD, John E Levine, MD MS

Blood (2016) 128 (22): 664.

https://doi.org/10.1182/blood.V128.22.664.664

Published: 2016

Journal Articles

Incidence and Risk Factors for Hypogammaglobulinemia in Pediatric Allogeneic Stem Cell Transplant (SCT) Patients

Haydar Frangoul, MD, Elliot Min, BS, Zengqi Lu, Mario Mario, PhD, Richard Ho, MD, Valerie Brown, MD, PhD, Jennifer Domm, MD

Blood (2012) 120 (21): 4492.

https://doi.org/10.1182/blood.V120.21.4492.4492

Published: 2012

Journal Articles

Risk of Bacterial Infection in Pediatric Hematopoietic Stem Cell Transplant Patients Receiving Cephalosporin Prophylaxis

Amanda Berger, PharmD, Haydar Frangoul, MD, Katie Bruce, PharmD, Steve Ampah, MS

Blood (2012) 120 (21): 4497.

https://doi.org/10.1182/blood.V120.21.4497.4497

Published: 2012

Journal Articles

Safety and Immunogenicity of High Dose Trivalent Inactivated Influenza Vaccine in Pediatric Patients with Acute Lymphoblastic Leukemia

Meghann Pine McManus, DO, MPH, Haydar Frangoul, MD, Jonathan McCullers, MD, Wenli Wang, MS, Steve Ampath, MS, Alice O'Shea, RN, Natasha Halasa, MD, MPH

Blood (2012) 120 (21): 3531.

https://doi.org/10.1182/blood.V120.21.3531.3531

Published: 2012

Journal Articles

The Effect of Transplant Center Characteristics On Survival After Pediatric Hematopoietic Cell Transplantation

Michael J Eckrich, MD, MPH, Jennifer Le-Rademacher, PhD, J. Douglas Rizzo, MD, MS, K. Scott Baker, MD, MS, Deepika Bhatla, MD, David K. Buchbinder, M.D., M.S.H.S., Kenneth R. Cooke, MD, Reggie Duerst, MD, Andrew Gilman, MD, Haydar Frangoul, MD, Neena Kapoor, MD, Nancy A. Kernan, MD, Michael Verneris, MD, Mary Eapen, MBBS

Blood (2012) 120 (21): 762.

https://doi.org/10.1182/blood.V120.21.762.762

Published: 2012

Journal Articles

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders

John Horan, Tao Wang, Michael Haagenson, Stephen R. Spellman, Jason Dehn, Mary Eapen, Haydar Frangoul, Vikas Gupta, Gregory A. Hale, Carolyn K. Hurley, Susana Marino, Machteld Oudshoorn, Vijay Reddy, Peter Shaw, Stephanie J. Lee, Ann Woolfrey

Blood (2012) 120 (14): 2918–2924.

https://doi.org/10.1182/blood-2012-03-417758

Published: 2012

Journal Articles

Outcome of Children Who Experience Disease Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies,

Rajinder PS Bajwa, MBBS, MD, MRCP, Sandeep Soni, MBBS, Tal Schechter, MD, Adam Gassas, MD, John J Doyle, MD, India Sisler, MD, Kamar Godder, MD, MPH, David Tatman, BA, Stephen Rumelhart, MD, Jennifer Domm, MD, Haydar Frangoul, MD

Blood (2011) 118 (21): 4101.

https://doi.org/10.1182/blood.V118.21.4101.4101

Published: 2011

Journal Articles

Targeting Busulfan to Concentration Steady State of 600–700 ng/Ml Is Associated with Robust Engraftment and Decreased Toxicity in Patients with Sickle Cell Disease Receiving An HLA Identical Donor Transplant

Jennifer Domm, MD, Elizabeth Yang, MD, PhD, Richard Ho, MD, Adetola a Kassim, MD, Haydar Frangoul, MD

Blood (2011) 118 (21): 1966.

https://doi.org/10.1182/blood.V118.21.1966.1966

Published: 2011

Journal Articles

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors

Blood (2010) 116 (19): 4007–4015.

https://doi.org/10.1182/blood-2010-01-261958

Published: 2010

Includes: Supplemental data

Journal Articles

The Effect of Obesity On Outcome of Unrelated Cord Blood Transplant in Children with Malignant Diseases.

S. Pine Meghann, DO, MPH, Li Wang, MS, Frank Harrell, PhD, Richard Ho, MD, Jennifer Domm, MD, Haydar Frangoul, MD

Blood (2009) 114 (22): 2278.

https://doi.org/10.1182/blood.V114.22.2278.2278

Published: 2009

NARROW

Improvements in Health-Related Quality of Life after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Improvements in Health-Related Quality of Life after Exagamglogene Autotemcel in Patients with Transfusion-Dependent Beta-Thalassemia

AsCas12a Gene Editing of HBG1/2 Promoters with EDIT-301 Results in Rapid and Sustained Normalization of Hemoglobin and Increased Fetal Hemoglobin in Patients with Severe Sickle Cell Disease and Transfusion-Dependent Beta-Thalassemia

Differing Definitions of Vaso-Occlusion in Clinical Studies of Sickle Cell Disease Can Result in Differing Outcomes

Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Severe Sickle Cell Disease

Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+ Hematopoietic Stem and Progenitor Cells

Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN)

Comparison of Outcomes for Myeloablative Conditioning Regimens Combining Busulfan with Either Cyclophosphamide or Fludarabine in Children

Incidence and Risk Factors for Hypogammaglobulinemia in Pediatric Allogeneic Stem Cell Transplant (SCT) Patients

Risk of Bacterial Infection in Pediatric Hematopoietic Stem Cell Transplant Patients Receiving Cephalosporin Prophylaxis

Safety and Immunogenicity of High Dose Trivalent Inactivated Influenza Vaccine in Pediatric Patients with Acute Lymphoblastic Leukemia

The Effect of Transplant Center Characteristics On Survival After Pediatric Hematopoietic Cell Transplantation

Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders

Outcome of Children Who Experience Disease Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies,

Targeting Busulfan to Concentration Steady State of 600–700 ng/Ml Is Associated with Robust Engraftment and Decreased Toxicity in Patients with Sickle Cell Disease Receiving An HLA Identical Donor Transplant

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors

The Effect of Obesity On Outcome of Unrelated Cord Blood Transplant in Children with Malignant Diseases.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only